Evidence map›Paper›PMID 34178329›Full record

ArticleClinical & translational immunology2021

IL-33/ST2 axis deficiency exacerbates neutrophil-dominant allergic airway inflammation.

Qiyun Ma, Yan Qian, Jingxian Jiang, Jingjing Wu, Meijuan Song, Xinyu Li, Zhongqi Chen, Zhengxia Wang, Ranran Zhu, Zhixiao Sun and 3 more

Open access · goldAbstract read
In one paragraph

Article in Clinical & translational immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Serum IL-33/ST2 Axis Expression in Acute Exacerbations of COPD: Correlation with Pulmonary Function.International journal of chronic obstructive pulmonary disease · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Qiyun MaDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Yan QianDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Jingxian JiangDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Jingjing WuDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Meijuan SongDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Xinyu LiNHC Key Laboratory of Antibody Technique Jiangsu Key Laboratory of Pathogen Biology Department of Immunology Nanjing Medical University Nanjing China.
Zhongqi ChenDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Zhengxia WangDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Ranran ZhuDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Zhixiao SunDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Mao HuangDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Ningfei JiDepartment of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China.
Mingshun ZhangNHC Key Laboratory of Antibody Technique Jiangsu Key Laboratory of Pathogen Biology Department of Immunology Nanjing Medical University Nanjing China.ORCID https://orcid.org/0000-0001-5925-0168
Jiangsu Province Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe IL-33/ST2 axis has been extensively investigated in type 2 eosinophilic inflammation. Here, we aimed to investigate the role of the IL-33/ST2 axis in neutrophil-dominant allergic airway inflammation.

methodsHouse-dust mite (HDM) extract and lipopolysaccharide (LPS) were administered to establish a murine model of neutrophil-dominant allergic airway inflammation. The formation of neutrophilic extracellular traps (NETs) in the lung tissues was demonstrated by immunofluorescence imaging. Mature IL-33 in bronchoalveolar lavage fluid (BALF) was detected by Western blotting. The neutrophilic chemokine KC produced by bone marrow-derived macrophages (BMDMs) or primary alveolar epithelial cells was measured with a commercial ELISA kit.

resultsIn the present study, we observed neutrophilic inflammation and tight junction damage in the lungs of mice sensitised with HDM and LPS. Furthermore, sensitisation with HDM and LPS resulted in the formation of NETs, accompanied by increased levels of mature IL-33 in the BALF. Moreover, LPS damaged the epithelial tight junction protein occludin directly or indirectly by inducing NET formation. Surprisingly, IL-33 deficiency augmented neutrophilia and epithelial barrier injury in the lungs of mice after sensitisation with HDM and LPS. Similarly, the absence of ST2 exacerbated the neutrophilic inflammatory response, decreased the expression of occludin and exacerbated the severity of neutrophil-dominant allergic airway inflammation in an HDM/LPS-induced mouse model. Mechanistically, BMDMs and alveolar epithelial cells from IL-33- or ST2-deficient mice tended to produce higher levels of the neutrophilic chemokine KC.

conclusionsThese results demonstrated that the IL-33/ST2 axis may play a protective role in neutrophil-dominant allergic airway inflammation.

Indexed as

animal modelsasthmabarrierepitheliuminflammation

Identifiers

PMID34178329
PMCPMC8207976
OpenAlexW3168250333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.